Vertex, Inc. (LON:0A3L)
| Market Cap | 1.51B -67.6% |
| Revenue (ttm) | 581.63M +11.8% |
| Net Income | -4.87M |
| EPS | -0.03 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 13.60 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 120 |
| Average Volume | 1,062 |
| Open | 13.93 |
| Previous Close | 13.77 |
| Day's Range | 13.62 - 14.25 |
| 52-Week Range | 10.63 - 42.36 |
| Beta | 0.80 |
| RSI | 50.02 |
| Earnings Date | May 7, 2026 |
About Vertex
Vertex, Inc., together with its subsidiaries, provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally. The company offers transaction determination; compliance and reporting, including workflow management tools; tax data management and document management solutions; analytics and insights; pre-built integration that includes mapping data fields, and business logic and configurations; industry-specific solutions support certain industries for indirect t... [Read more]
News
Vertex price target lowered to $14 from $16 at Jefferies
Jefferies lowered the firm’s price target on Vertex (VERX) to $14 from $16 and keeps a Hold rating on the shares. The firm updated models in the software group following…
Vertex price target raised to $15 from $13 at DA Davidson
DA Davidson raised the firm’s price target on Vertex (VERX) to $15 from $13 and keeps a Neutral rating on the shares after its Q1 earnings beat. The management highlighted…
Vertex price target raised to $19 from $18 at Morgan Stanley
Morgan Stanley analyst Chris Quintero raised the firm’s price target on Vertex (VERX) to $19 from $18 and keeps an Overweight rating on the shares.
Vertex price target raised to $16 from $15 at Citi
Citi raised the firm’s price target on Vertex (VERX) to $16 from $15 and keeps a Neutral rating on the shares.
Vertex price target lowered to $21 from $23 at Goldman Sachs
Goldman Sachs analyst Adam Hotchkiss lowered the firm’s price target on Vertex (VERX) to $21 from $23 and keeps a Buy rating on the shares. The stock’s post-earnings gains are…
Vertex reports Q1 EPS 17c, consensus 16c
Reports Q1 revenue $196.65M, consensus $194.82M. “We delivered a strong first quarter, with revenue and adjusted EBITDA above the higher end of our guidance as well as stability across customer…
Vertex sees Q2 revenue $200M-$204M, consensus $203.14M
Sees Q2 adjusted EBITDA $47M-$50M.
Vertex backs FY26 revenue view $823.5M-$831.5M, consensus $827.21M
Raises FY26 adjusted EBITDA view to $202M-$208M. Young concluded, “In April, we announced our Value Creation Plan, which is expected to further transform Vertex (VERX) into a more effective, AI-leadin...
Vertex Earnings Call Transcript: Q1 2026
Q1 2026 revenue and adjusted EBITDA exceeded guidance, driven by strong e-invoicing and cloud growth, with customer retention stable at 95%. Cost actions and the Brinta acquisition support reinvestment in AI and compliance, while full-year EBITDA guidance was raised and profitability targets accelerated to 2027.
Vertex Announces First Quarter 2026 Financial Results
KING OF PRUSSIA, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading provider of enterprise compliance technology for global commerce, today announ...
Vertex price target lowered to $18 from $20 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $18 from $20 and keeps an Overweight rating on the shares.
Vertex to Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026
KING OF PRUSSIA, Pa., April 13, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading provider of enterprise compliance technology for global commerce, today announced that it will release fi...
VERTEX Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Vertex, Inc. (NASDAQ: VERX). The investigation focuses on Vertex's execut...
Vertex O Series Tax Engine available on Oracle Marketplace
Vertex (VERX) announced Vertex O Series Tax Engine and Indirect Tax Accelerator for Oracle’s (ORCL) ERP offerings are available on the Oracle Marketplace and can be deployed on Oracle Cloud…
Vertex Stock Jumps. What Wall Street Is Saying About Its Kidney Drug Trial.
The drug maker says its treatment of a rare kidney disease met its main goal in a late-stage trial.
Vertex Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026
The company is leveraging global compliance trends and AI innovation to drive growth, focusing on e-invoicing mandates, product enhancements, and operational efficiency. While ARR growth slowed in 2025, strong new logo wins and expanding AI capabilities are expected to boost future performance.
Vertex Transcript: Citizens JMP Technology Conference 2026
Leadership highlighted strong customer trust, global expansion, and a focus on AI-driven innovation. E-invoicing mandates and compliance are major growth drivers, with investments in customer retention and product enhancements positioning the company for 2026 and beyond.
Vertex to Present at Upcoming Conferences
KING OF PRUSSIA, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX), a global provider of tax technology solutions, today announced that Chris Young, President and Chief Executive Offi...
Vertex price target lowered to $13 from $23 at DA Davidson
DA Davidson lowered the firm’s price target on Vertex (VERX) to $13 from $23 and keeps a Neutral rating on the shares. The company’s Q4 results were largely in line…
Vertex price target lowered to $16 from $22 at BMO Capital
BMO Capital lowered the firm’s price target on Vertex (VERX) to $16 from $22 and keeps a Market Perform rating on the shares. The company’s 2025 results were negatively impacted…
Vertex price target lowered to $23 from $25 at Goldman Sachs
Goldman Sachs analyst Adam Hotchkiss lowered the firm’s price target on Vertex (VERX) to $23 from $25 and keeps a Buy rating on the shares. Shares fell 13% on the…
Vertex price target lowered to $20 from $33 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Vertex (VERX) to $20 from $33 and keeps an Overweight rating on the shares.
Vertex price target raised to $119 from $25 at Baird
Baird analyst Rob Oliver raised the firm’s price target on Vertex (VERX) to $119 from $25 and keeps an Outperform rating on the shares. The firm updated its model following…
Vertex price target lowered to $15 from $22 at Citi
Citi lowered the firm’s price target on Vertex (VERX) to $15 from $22 and keeps a Neutral rating on the shares.
Vertex price target lowered to $25 from $37 at Citizens
Citizens lowered the firm’s price target on Vertex (VERX) to $25 from $37 and keeps an Outperform rating on the shares. The company delivered mostly disappointing Q4 results, with slowing…